HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of malignant glioma cells with the transfer of constitutively active caspase-6 using the human telomerase catalytic subunit (human telomerase reverse transcriptase) gene promoter.

Abstract
Because the apoptotic pathway is often disrupted in tumor cells, its genetic restoration is a very attractive approach for the treatment of tumors. To treat malignant gliomas with this approach, it would be preferred to restrict induction of apoptosis to tumor cells by establishing a tumor-specific expression system. Telomerase is an attractive target because the vast majority of malignant gliomas have telomerase activity whereas normal brain cells do not. Activation of telomerase is tightly regulated at the transcriptional level of the telomerase catalytic subunit [human telomerase reverse transcriptase, (hTERT)]. Therefore, we hypothesized that using a hTERT promoter-driven vector system, an apoptosis-inducible gene may be preferentially restricted to telomerase- or hTERT-positive tumor cells. In this study, we constructed an expression vector consisting of the constitutively active caspase-6 (rev-caspase-6) under the hTERT promoter (hTERT/rev-caspase-6) and then investigated its antitumor effect on malignant glioma cells. The rationale for using the rev-caspase-6 gene is because it induces apoptosis independent of the initiator caspases. We demonstrated that the hTERT/rev-caspase-6 construct induced apoptosis in hTERT-positive malignant glioma cells, but not in hTERT-negative astrocytes, fibroblasts, and alternative lengthening of telomeres cells. In addition, the growth of s.c. tumors in nude mice was significantly suppressed by the treatment with hTERT/rev-caspase-6 construct. The present results strongly suggest that the telomerase-specific transfer of the rev-caspase-6 gene under the hTERT promoter is a novel targeting approach for the treatment of malignant gliomas.
AuthorsT Komata, Y Kondo, T Kanzawa, S Hirohata, S Koga, H Sumiyoshi, S M Srinivasula, B P Barna, I M Germano, M Takakura, M Inoue, E S Alnemri, J W Shay, S Kyo, S Kondo
JournalCancer research (Cancer Res) Vol. 61 Issue 15 Pg. 5796-802 (Aug 01 2001) ISSN: 0008-5472 [Print] United States
PMID11479218 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • DNA-Binding Proteins
  • RNA, Messenger
  • telomerase RNA
  • RNA
  • Telomerase
  • CASP6 protein, human
  • Casp6 protein, mouse
  • Caspase 6
  • Caspases
Topics
  • Animals
  • Apoptosis (genetics)
  • Caspase 6
  • Caspases (biosynthesis, genetics, metabolism)
  • DNA-Binding Proteins
  • Gene Transfer Techniques
  • Genetic Therapy (methods)
  • Genetic Vectors (genetics)
  • Glioma (enzymology, genetics, pathology, therapy)
  • Humans
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • Promoter Regions, Genetic (genetics)
  • RNA
  • RNA, Messenger (biosynthesis, genetics)
  • Telomerase (biosynthesis, genetics)
  • Transcriptional Activation
  • Tumor Cells, Cultured
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: